Publicaciones (58) Publicaciones de Emilio Fonseca Sánchez

2024

  1. Acute pulmonary embolism masking a pulmonary artery sarcoma

    Medicina Clinica

  2. COMPLICATIONS SECONDARY TO THE USE OF SGLT2 INHIBITORS IN ONCOLOGICAL PATIENTS: A SERIES OF 5 CASES

    European Journal of Case Reports in Internal Medicine, Vol. 11, Núm. 1

  3. Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases

    Life, Vol. 14, Núm. 7

  4. Cáncer de colon y recto

    Oncología clínica (Arán), pp. 303-317

  5. Cáncer gástrico, de páncreas y de las vías biliares

    Oncología clínica (Arán), pp. 273-289

  6. Descriptive Study on the Relationship between Dyspnea, Physical Performance, and Functionality in Oncology Patients

    Healthcare (Switzerland), Vol. 12, Núm. 16

  7. Effects of a Resistance Exercise Program in Patients with Colorectal Cancer Undergoing Chemotherapy Treatment: A Randomized Controlled Trial Study Protocol

    Journal of Clinical Medicine, Vol. 13, Núm. 15

  8. Impact of a multimodal effort re-education programme on functionality, physical performance, and functional capacity in cancer patients with dyspnoea: a randomised experimental study

    Supportive Care in Cancer, Vol. 32, Núm. 10

  9. Late recurrence of lobular breast carcinoma presented as gastric metastasis

    Revista espanola de enfermedades digestivas, Vol. 116, Núm. 8, pp. 455-456

  10. No one writes to the colonel: (Pag.-e 102173)

    Semergen: revista española de medicina de familia, Núm. 4, pp. 10-10

  11. Oncología clínica coord.

    Arán

  12. PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer

    Cancer Medicine, Vol. 13, Núm. 17

  13. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review

    Chinese Clinical Oncology, Vol. 13, Núm. 3

  14. Study on the additional financial burden of breast cancer disease on cancer patients and their families. Financial toxicity in cancer

    Frontiers in Public Health, Vol. 12

2023

  1. Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality

    Precision Cancer Medicine

  2. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  3. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  4. Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»

    Revista Espanola de Geriatria y Gerontologia

2022

  1. Acquired haemophilia A secondary to metastatic prostate cancer

    Medicina Clinica

  2. Acute esophageal necrosis induced by immune checkpoint inhibitors

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 3, pp. 182-183